Consistent with previous studies, the overexpression of C/EBPβ results in a decrease in E‐cadherin levels while simultaneously increasing the levels of N‐cadherin and vimentin, suggesting that C/EBPβ drives NSCLC metastasis through EMT. The gene discussed is CDH2; the disease is non-small cell lung carcinoma.